Team:Slovenia/Conclusions
From 2008.igem.org
Line 168: | Line 168: | ||
Achievements | Achievements | ||
- | + | <html> | |
- | + | <div style="text-align:justify"><br /> | |
- | + | <ul> | |
- | + | <li>We have demonstrated the power of modular building blocks approach of synthetic biology (IMMUNOBRICKS) for the rational design of vaccines</li> | |
- | + | <li>We have designed a new type of vaccine against H. pylori based on chimeric flagellin that combines activation of innate and adaptive immunity in the same molecule | |
- | + | <ul> | |
- | + | <li>Chimeric flagellins were produced in bacteria, purified and characterized</li> | |
- | + | <li>Engineered flagellins activate TLR5 as opposed to the native H. pylori flagellin</li> | |
- | + | <li>three different implementations of chimeric flagellin vaccines were prepared</li> | |
- | + | <li>chimeric flagellin is localized at the bacterial surface</li> | |
- | + | <li>DNA construct based on chimeric flagellin activates TLR5 on neighboring cells (demonstration of the feasibility of introduction of DNA into epithelial cells to activate underlying dendritic cells)</li> | |
- | + | </ul> | |
- | + | </li> | |
- | + | <li>Antigen-TLR fusions are functional and their localization can be modulated by the selection of transmembrane segment</li> | |
- | + | <li>Various DNA vaccine constructs have been successfully introduced by electroporation intramuscularly or subcutanelously and expression of the fusion protein in the target tissue in vivo was demonstrated</li> | |
- | + | </ul></div></html> | |
- | + | ||
- | + | ||
- | + | ||
Revision as of 00:18, 30 October 2008
|
|
| |
|
|
Achievements
· Complete animal studies: demonstrate the profilactic efficiency of our vaccines to prevent colonization, and therapeutic value to eradicate existing infection as well as evaluate effects of vaccinations on histology of gastric mucosa…… · Demonstrate the efficiency of bacterial implementation of flagellin-like vaccine on lyophilized bacterial ghosts (more safe and stable vaccine), particularly for oral and mucosal vaccination – prospects for application in third world countries · Analyze different combinations of antigen-TLRs to obtain optimal immune stimulation (TLR synergy) · Repeat all experiments with many controls, in comparison to currently used adjuvants etc
Prospects · Functional vaccine against H. pylori would be definitely welcome · The approach with chimeric flagellins could be used against other flagellated bacteria whose flagellin does not activate innate system (Bartonella, Campylobacter, Borellia...) · Could vaccines based on antigen-TLR fusions be used as tumor vaccines as well? · ... ... (ars longa, vita brevis) · Two chimeric recombinant protein vaccines showed intense IgG antibody response in mice and immunized sera also reacted with heat-killed H. pylori antigens implying that they recognize epitopes of H. pylori.
|
|
|